Dacarbazine

Brand name: DTIC-Dome

B

Score B — Known Hepatotoxin

This drug is known or highly likely to cause idiosyncratic liver injury and has a characteristic signature.

Between 12 and 50 cases including small case series have been described in the medical literature.

Primary class Antineoplastic
Secondary class Solid tumors, Lymphoma
FDA approval 1975